KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Net Income (2016 - 2025)

Bausch Health Companies' Net Income history spans 17 years, with the latest figure at -$103.0 million for Q4 2025.

  • For Q4 2025, Net Income fell 205.1% year-over-year to -$103.0 million; the TTM value through Dec 2025 reached $120.0 million, up 266.67%, while the annual FY2025 figure was $120.0 million, 266.67% up from the prior year.
  • Net Income for Q4 2025 was -$103.0 million at Bausch Health Companies, down from $181.0 million in the prior quarter.
  • Across five years, Net Income topped out at $403.0 million in Q3 2022 and bottomed at -$607.0 million in Q1 2021.
  • The 5-year median for Net Income is -$71.5 million (2022), against an average of -$85.6 million.
  • The largest annual shift saw Net Income tumbled 669.44% in 2022 before it skyrocketed 12900.0% in 2025.
  • A 5-year view of Net Income shows it stood at $72.0 million in 2021, then crashed by 669.44% to -$410.0 million in 2022, then skyrocketed by 88.54% to -$47.0 million in 2023, then surged by 308.51% to $98.0 million in 2024, then plummeted by 205.1% to -$103.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Net Income are -$103.0 million (Q4 2025), $181.0 million (Q3 2025), and $128.0 million (Q2 2025).